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Immunization by the gastrointestinal or respiratory mucosal routes is usually more 
effective at stimulating a secretory IgA response than parenteral delivery of antigen 
(1-3).  Secretory antibodies generated in  gastrointestinal  or respiratory mucosa can 
confer protection against  pathogens impinging on adjacent mucosal surfaces (3, 4). 
Nonreplicating antigens have traditionally been viewed as ineffective in priming for 
secretory immune  responses when  given either orally (5,  6)  or parenterally  (7,  8); 
however, recent studies using cholera toxin in rats (9, 10), dogs (11,  12), and mice (13, 
14)  have clearly demonstrated  priming  by this  antigen  for an  intestinal  secretory 
response  when  administered  by  oral,  intraduodenal,  and  even  parenteral  routes. 
Priming was scored by enumerating toxoid-binding IgA plasma cells appearing in the 
gut lamina propria, after intestinal challenge with toxin (9-14). The density of such 
cells in the intestine correlates with protection against the toxic effects of the enterically 
delivered antigen (9,  12, 14). This priming process, which results in the generation of 
appreciable numbers of antigen-specific IgA plasmablasts in gut lamina propria after 
secondary toxin challenge, probably includes several events:  (a)  antigen-stimulated 
expansion  and  differentiation of a  specific B  cell subpopulation;  (b)  generation of 
specific  helper  T  cells  necessary  for  the  maturation  of plasmablasts  and  the  T- 
dependent expression of IgA antibodies; and (c) the in vivo redistribution of antigen- 
specific B and T  cells. We have adapted the rat model of priming for a gut mucosal 
IgA  response  against  cholera  toxin  to  the  inbred  mouse  in  order  to  resolve these 
various  aspects  of priming  by  taking  advantage  of the  procedures  available  for 
analyzing individual murine B cells (15). 
Peyer's patches (pp)l, compared with lymph nodes or spleen, naturally contain a 
higher frequency of precursors for IgA plasma cells of certain specificities, but not of 
others (16,  17). However, it is not known where IgA-committed B cells originate or 
whether the natural antigen load in the gut affects their distribution. Because cholera 
toxin  is  not  usually  an  environmental  antigen,  its  administration  could  permit  a 
controlled re-enactment of the natural  priming process that  commensal  organisms 
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achieve by colonization in  the  neonate  (17).  The present  report  compares mucosal 
with parenteral  routes of cholera toxin/toxoid  2 delivery for stimulation of antigen- 
specific B cells  found in PP and in other lymphoid tissues. 
After  a  secondary  toxin  challenge  in  the  gut,  the  PP  contribute  to  the  IgA 
plasmablasts seen in thoracic duet lymph and then in intestinal lamina propria (18). 
Direct  priming of PP cells  in  situ  after  initial  gut  mucosal administration  of toxin 
would explain  this contribution to the  response, but  observations in the rat  model 
indicate that intraperitoneal  injection of antigen is also effective at priming for the 
expression of IgA plasmablasts in response to intestinal challenge. The mechanism by 
which parenteral delivery of antigen affects mucosal lymphoid tissue is unclear, and 
the general observation that  immunization by the mucosal route usually favors the 
lgA response  remains  unexplained.  We  have  therefore  examined  that  part  of the 
priming process by cholera  toxin/toxoid  reflected  by quantitative  and  qualitative 
changes in the B cell population. 
This paper shows that a primary exposure of mice to cholera toxin/toxoid by either 
the gut mucosal or parenteral route results in a  marked increase in antigen-sensitive 
B cells with secondary characteristics in PP and elsewhere. These cells generate clones 
in  vitro  that  express  IgG  and/or  IgA  isotypes.  Mucosal  exposure  favors  higher 
frequencies of secondary cells  committed  to  the  exclusive  generation  of daughters 
expressing IgA. Such precursors of clones producing only IgA are more prevalent in 
PP after mucosal stimulation but exist in significant numbers at distant sites  as well. 
The observations are consistent with our model for B cell development  (19,  20),  in 
which permanent commitment of a B cell line to IgA expression is dependent on cell 
division and is favored when the proliferative stimulus is given in mucosal follicles. 
Materials and Methods 
Animals.  BALB/cJ male mice were purchased  from The Jackson Laboratory, Bar Harbor, 
Maine.  Mice were immunized at 5-8 wk of age. 
Antigens  and  Immunization  Methods.  Purified  Vibrio cholera enterotoxin,  lots  OZ3052  and 
EZ3566, was purchased  from  Schwarz/Mann Div., Becton,  Dickinson  & Co.,  Orangeburg, 
N. Y. Glutaraldehyde-inactivated  cholera toxoid vaccine, Wyeth lot 20201, was the kind gift of 
Dr. Carl Miller, National Institute of Allergy and Infectious Diseases. 
Intraduodenal priming was accomplished  by direct  injection of 10/~g of purified  toxin, in 
0.2% gelatin/phosphate-buffered  saline (PBS), at the most proximal end of the small intestine 
after a small laporotomy.  Intraperitoneal immunizations  used  100/xg toxoid  in gelatin/PBS 
with complete Freund's adjuvant (CFA). 
Lamina Propria Plasma Cell Scoring.  Single-cell  suspensions of intestinal  lamina propria were 
prepared  according to a  previously  published  method  (21). In  some cases, contaminating 
epithelial  cells were removed  by separation  on a  Pereoll  (Pharmacia Fine  Chemicals,  Inc., 
Uppsala,  Sweden) gradient  by a  modification  of the technique  of Curman et  al.  (22). The 
intestinal cell preparation was suspended in 33% isotonic Pereoll in PBS, and spun at 17,000  g 
for 30 min at 4°C. Epithelial  cells appear in the top third of the self-formed gradient,  whereas 
viable lymphoid cells can be isolated from the bottom third. 
Thick smears of these lymphoid cells were fixed in 95% ethanol  and stained  for antitoxoid 
containing plasma cells (ACC), using the fluorescent sandwich technique  developed by Pierce 
et al. (9) for staining rat tissues. The toxoid solution for the first step and the fluorescein-labeled 
rabbit antitoxoid  were the kind  gifts of Dr. Nathaniel  Pierce, The Johns Hopkins  University 
2  Cholera toxin/toxoid is used to denote the toxin antigen or its cross-reactive, but nontoxic glutaral- 
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School of Medicine, Baltimore, Md. A rhodamine-conjugated rabbit antitoxoid was prepared 
in our laboratory. 
Enumeration of Antigen-sensitive Cells.  At various times after immunization, toxoid-sensitive B 
cells in various tissues were enumerated using a modification of the Klinman elonal precursor 
assay  (15).  The  tissue to be scored was  dispersed into single cells and  injected at  limiting 
dilution into the tail vein of lethally irradiated (1,500  tad), toxoid-primed scoring recipients. 
After  16-24  h,  the  recipients' spleens were  removed and  diced into  ~50  fragments.  These 
fragments were distributed individually among the wells of a microtiter plate, and challenged 
in culture for 4 d  with purified cholera toxoid at a  10-~-10  -s M  concentration in Dulbeceo's 
modified Eagle's minimal essential medium with 10% agamma horse serum (both from Grand 
Island Biological Co., Grand Island, N. Y.). The fragments were then washed free of antigen, 
and  maintained  in  organ  culture  for  an  additional  11  d  with  regular changes  of culture 
medium.  Culture  fluids were  then  assayed for antitoxoid antibodies by radioimmunoassay 
(RIA). The supernatant fluids collected from an individual positive fragment were pooled and 
used to determine the amount and isotype of antitoxoid antibody produced by the clone of cells 
contained in that fragment. 
RIA.  A solid-phase RIA was developed for scoring antitoxoid antibodies in splenic fragment 
culture  fluids.  Bromoacetyleelluiose  (1  g  wet  wt)  was  derivatized  with  360  mg  each  of 
diaminohexane  and  ~-aminocaproie acid  at  pH  8.9,  followed  by  extensive washing.  This 
aminohexyl cellulose derivative was then added to 5 mg of purified cholera toxoid that  had 
been activated wwih  1-ethyl-3-(3~dimethylaminopropyl)  earbodiimide (Story Chemical Corp., 
Muskegon, Mich.). Coupling proceeded at room temperature for 8  h, followed by extensive 
washing to remove noncovalently bound toxoid. This solid support was then used in a standard 
RIA  procedure  (23)  with  lmI-labeled rabbit  anti-mouse  Fab  or  rabbit  anti-mouse  isotype 
scoring reagents. 
Results 
Mucosal  or Parenteral  Stimulation  with  Antigen  Can  Prime for an  Intestinal  Plasma  Cell 
Response to Subsequent  Intraduodenal  Challenge  with Toxin.  It has been demonstrated (14) 
that intestinal ACC responses in the mouse require at least two oral challenges with 
cholera toxin, whereas as many as seven intravenous challenges result in about one- 
third the density of ACC in the gut. It was therefore of interest to determine whether 
both priming procedures we planned to analyze in the mouse did in fact result in a 
toxoid-binding plasma cell response in gut lamina propria after intraluminal challenge 
with toxin. Table I shows that both intraperitoneal and intraduodenal priming result 
in similar ACC frequencies (0.3 and 0.25%, respectively, of total lymphoid cells) at 5 
d  after a  secondary mucosal challenge with toxin. 
However, the secondary responses in the gut resulting from priming with antigen 
TABLE  I 
Plasma Cell Populations in Lamina Propria 5 d after Toxin Challenge 
Priming, 14 d before challenge 
Toxoid/CFA  Toxin i.d.:]:  i.p.* 
(clg+/total mononuclear cells) X 100% 
(ACC/total mononuclear cells) ×  100% 
(ACC/clg  +) ×  100% 
(cIgA+/ACC) × 100% 
(eIgM+/ACC) ×  100% 
(cIgG-~/ACC) ×  100% 
4  2 
0.3  0.25 
8  12 
20  90 
5  0-3 
80  10 
* Intraperitoneal. 
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FIG.  1.  Enumeration of antitoxoid clonal precursors at various times after intraduodenal priming 
(~') with 10/~g cholera toxin. All points represent at least ,50 ×  l0  s cells scored. Spl, spleen; BALT, 
bronchus-associated lymphoid tissue. 
by the two different routes are dissimilar in their isotype characteristics. Whereas 90% 
of the antigen-specific plasma cells in intraduodenally primed and challenged mice 
contain cytoplasmic IgA, only 20% of the ACC from intraperitoneally primed mice 
contain  IgA,  and  the  remainder  contain  mostly  IgG  isotypes.  This  observation 
supports the general finding that mucosal priming is more efficacious for generating 
secretory IgA responses (1-4), but the basis for this disparity in the primed cell types 
resulting from the different routes of immunization remains unclear. To analyze these 
differences, the effects of priming on the B cell populations found in various lymphoid 
tissues were investigated. 
Intraduodenal Priming  with Cholera Toxin Increases the Frequency of Antigen-sensitive  Cells 
in  PP and in  Distant  Lymphoid  Tissues.  The  frequency of toxoid-reaetive B  cells  in 
normal young adult  mouse tissue was first ascertained to serve as a  base-line value 
against  which  any  increase  in  frequency  could  be judged.  Such  an  increase  in 
frequency of antigen-sensitive cells can be considered a  quantitative index of B cell 
priming. Fig.  1 shows that all tissues analyzed by the clonal precursor method from 
unprimed mice (day 0) show frequencies of toxoid-sensitive cells between 1 and 3 per 
106 B  cells.  Previous studies  (16,  17)  have shown that  frequencies of this order are 
found in germ-free or neonatal animals for B cells reactive with common bacterial 
determinants such as ]32 --, 1 fructosyl or phosphocholine, whereas conventional young 
adult mice, presumably after enteric bacterial association, show frequencies elevated 
by at least an order of magnitude. Thus, our results suggest that BALB/c mice are 
naturally in an unprimed state for specificities associated with toxin/toxoid. 
Next,  the  resultant  levels  of B  cell  priming  at  different  lymphoid  sites  were 
compared after mucosal administration of the antigen. Lymphoid tissues were excised 
from groups of mice (5-10 per group)  at various times after a  single intraduodenal 
challenge with 10/xg cholera toxin, and each tissue type was individually assayed by 
the  clonal  precursor  method.  Fig.  1 shows  that  2  wk  after mucosal  priming,  the 
frequency of toxoid-reactive B cells in PP increased approximately fivefold. Further- 
more, the frequency continued to increase at 4  wk and 6 wk postpriming, and the 
elevated frequency was maintained in the PP even at  12 wk, the latest time tested. 538  PRIMING FOR  AN ANTITOXIN SECRETORY  IgA  RESPONSE 
128 
64 
4O 
•  ~  32 
U 
o.  8i 
_o 
AMI.  N 
WEEKS 
Fro.  2.  Enumeration ofantitoxoid clonal precursors at various times after intraperitoneal priming 
(1') with 100/~g  cholera toxoid in CFA. All points represent at least 50 ×  106 cells scored. Spl, spleen. 
TABLE II 
lsotype Profile of PP-derived  Antitoxoid Clones 
B cell donors 
Week after i.p 
Clonal product  Week after i.d. priming*  priming~ 
0  2  4  6  12  2  12 
Antitoxoid clones expressing product 
% 
/L only  5  0  0  0  0  0  0 
Some ~  75  4  11  15  75  61  5 
y + a, no/x  10  45  55  62  8  28  90 
Some a  20  77  72  85  100  50  42 
0t only  10  50  33  23  17  l I  10 
Number of clones  20  22  18  13  12  18  19 
analyzed 
* 10/~g purified cholera toxin injected intraduodenally (i.d.). 
:~ 100 #g cholera toxoid injected intraperitoneally (i.p.) with CFA. 
This  antigen-driven expansion  of clonal  precursors  was  also  reflected  in  tissues 
distant from the site of antigen application. A  single intestinal dose of purified cholera 
toxin caused an increase of reactive B  cells at distant mucosal sites of the respiratory 
tract,  as  well  as  in  mesenteric  lymph  node  (MLN)  and  spleen  (Fig.  1).  Again,  the 
elevated frequencies of antigen-sensitive cells at these distant sites persisted for at least 
12 wk after the intestinal challenge, remaining 30- to  100-fold above the background 
frequencies of unimmunized  mice. 
Comparison of Intraduodenal and Parenteral Priming of Mucosal and Nonmucosal B  Cell 
Populations.  We  next  examined  the  expansion  of  toxoid-sensitive  B  cell  pools  in 
various tissues after parenteral priming. The increase in toxoid-specific clonal precur- 
sors  after intraperitoneal immunization was  comparable  to that  resulting from  mu- 
cosal  priming  (Fig.  2).  This  increase occurs  in  mucosal  follicles,  lymph  nodes,  and 
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above  the  background  frequencies  in  unprimed  mice.  The  elevated  frequencies 
resulting from intraperitoneal priming, however, did not reach as high a level as after 
intraduodenal  priming.  By  12-14 wk  postpriming,  frequencies in  intraperitoneally 
primed mice were -50% or less of these values in the same tissue from intraduodenally 
primed mice. 
Isotype Potential of Secondary PP Cells Depends on the Route of Immunization.  The clonal 
precursor assay allows not only the enumeration of antigen-sensitive precursors, but 
also an analysis of the isotype potential of their clonal progeny expressed over 8-10 
generations (15). Antitoxoid-producing clones derived from donor tissues after priming 
by intraduodenal and intraperitoneal routes were therefore analyzed for their isotype 
profiles to determine whether priming route correlated with isotype potential. 
Table II classifies the antitoxoid clones from PP tissues of unprimed mice. Naive 
animals  showed  a  population  profile for clones typical of primary  B  cells, with  a 
predominance of clones  (75%)  producing IgM,  mostly  in  combination  with  other 
isotypes.  A  low  percentage of antitoxoid clones  (10%)  from  these  unprimed  mice 
already displayed a commitment to exclusive IgA production. Shortly after intradu- 
odenal priming, the isotype potential of antitoxoid clonal precursors in the PP shifted 
to a  more secondary character.  Less than 5% of the clones analyzed produced any 
IgM, expression of IgG isotypes was  increased more than  fourfold, and  more than 
three-quarters of all  clones produced some IgA.  The most  striking feature of these 
clones is  that  half of them  expressed IgA exclusively. This class of IgA-committed 
clonal precursors waned at later times after priming, but remained elevated above the 
unprimed  level  even  at  12  wk  after  immunization.  The  overall  incidence  of IgA 
expression  by clones  from  the  primed  cells  remained  high  at  all  times  tested.  A 
depressed frequency of clones expressing IgM  was  seen  immediately after priming 
and persisted for 6 wk. The return of antigen-sensitive cells giving clones expressing 
IgM was seen only after 12 wk. 
Although  a  decrease in  clones expressing IgM  from PP cells was  also  seen after 
parenteral priming, antigen administration by this route resulted in less substantial 
TABLE  III 
Isotype Profile of Spleen-derived Antitoxoid Clones 
Clonal product 
B cell donors 
Week after i.d.  priming*  Week after i.p.  priming:]: 
0  2-4  6  12  2  12 
Antitoxoid clones expressing product 
% 
# only  10  14  9  9  19  6 
Some ~  58  38  42  30  75  12 
y ±  a, no #  36  23  39  52  25  82 
Some 0t  21  62  69  56  38  18 
a  only  5  38  18  17  0  0 
Number of clones  19  13  33  23  16  17 
analyzed 
* Intraduodenal. 
:~ Intraperitoneal. 540  PRIMING  FOR  AN  ANTITOXIN SECRETORY  IgA  RESPONSE 
increases  in  any  IgA .expression.  Instead,  PP  clones  from  such  donors  showed  an 
increased expression of IgG isotypes. The secondary character which intraperitoneal 
priming imparted to the specific B cell population, even to those B cells recovered 
from  mucosal  follicles, was  manifested  as  increased  potential  for IgG  production, 
rather  than  the  commitment  to  exclusive  IgA  expression  generated  by  mucosal 
priming. Specifically, the route of priming was a  more significant factor than tissue 
residence in determining secondary B cell isotype potential. 
Splenic Cells Develop Different Isotype Potentials Depending on the Site of Antigen Adminis- 
tration.  Table  III  illustrates  the  isotype  potential  of spleen-derived  clones  from 
unprimed and  primed mice. Mucosally applied antigen  generated a  population of 
toxoid-specific clonal precursors in the spleen with a  threefold higher frequency of 
IgA production as compared with that of unprimed splenic tissue. In addition, the 
percentage of splenic clones committed to exclusive IgA production increased sub- 
stantially at early times after priming and remained elevated compared with unprimed 
tissue even at later times. 
Parenteral priming did not generate a similar population of splenic cells committed 
to exclusive IgA expression at any time tested, nor did it increase the total frequency 
of IgA production 'by resultant clones to a  level comparable with mucosal priming. 
The secondary character of parenterally primed splenic precursors was manifested as 
an elevated frequency of cells giving rise to IgG-producing clones seen at later times 
(3  mo)  after priming.  Thus, although  intraperitoneal priming does develop B  cells 
with secondary characteristics in both spleen and PP, this process occurs more slowly 
than after mucosal priming, and the potential to express non-IgM isotypes is quali- 
tatively different. 
Discussion 
The purpose of the present work was  to analyze the effects of different priming 
routes  on  antigen-specific B  lymphocyte populations  of mucosal  and  nonrnucosal 
lymphoid tissues. An assay was used that permits the enumeration of antigen-sensitive 
cells and analysis of their isotype potential over 8-10 generations (15). Antigen-specific 
clonal expansion of B cells is a  well-established feature of all priming processes for 
humoral immunity, but the nature of B cell priming in secretory immunity is poorly 
understood. We therefore chose to examine the antigen-specific response to cholera 
toxin because it has been found to prime effectively for a  secondary intestinal  IgA 
plasma  cell  response  when  administered  either  enterically or  parenterally  (9-14). 
Priming by the rnucosal, but not  the systemic, route requires that  the ganglioside- 
binding  activity of the  toxin  be  intact,  but  this  probably relates  to  the  resultant 
efficiency of transport across rnucosal surfaces such as the dome epithelium, rather 
than to effects on membrane permeability or any other toxic effect (10).  We have 
found that both enteric and parenteral antigen administration prime for a secondary 
intestinal  plasma  cell  response  in  the  mouse  similar  to  that  observed  in  the  rat. 
However, the mouse shows a distinction in plasma cell isotype profiles engendered by 
the two methods of priming, whereas this distinction is not as evident in the rat (9). 
Using the Klinman clonal precursor assay, we have elucidated several aspects of 
mucosal priming in the mouse. Both enteric and parenteral antigen were observed to 
increase markedly the frequency of toxoid-sensitive cells in all lymphoid tissues, and 
these resultant cells were predominantly secondary in nature, generating clones that JULIET  A.  FUHRMAN AND JOHN J. CEBRA  541 
express IgG and/or IgA but not IgM. There are two crucial aspects of this disseminated 
priming.  First,  both  priming  routes  generate  secondary cells  whose  progeny may 
express IgA. This indicates that either route, mucosal or parenteral, could include a 
mucosal IgA component as part of the overall response to secondary exposure of the 
gut to toxin/toxoid. Second, PP benefit from the clonal expansion and dissemination 
of toxoid-sensitive cells, regardless of the priming route, indicating that  parenteral 
priming  can  provide the  mucosal  system with  secondary memory B  cells.  This  is 
consistent with previous findings by Husband and Gowans (18), which indicated that 
ACC  appearing  in  the  thoracic  duct  lymph  of parenterally  primed  rats  after an 
intestinal challenge were of recent PP, and not MLN, origin. However, our studies do 
point to the possible contribution by MLN and spleen of antitoxoid IgA plasma cell 
precursors, regardless of priming route. 
It  should  be  noted  that  the  clonal  precursor  assay  has  certain  limitations  for 
studying the overall in vivo priming process for mucosal immunity. It can distinguish 
the generation, differentiation, and dissemination of primed memory B cells from that 
of their activated (effector) progeny plasma cells, but it cannot alone definitely predict 
the  timing,  magnitude,  or  site  of a  secretory  immune  response  in  vivo.  We  can 
evaluate  the  full  isotype potential  of B  cells in  a  particular  tissue,  but  the  useful 
expression of that  potential relies on a  multitude of factors also  influenced by the 
priming process, such as antigen encounter, plasmablast migration and lodging, and 
the balance of T-dependent help or suppression  at  sites of antigen  encounter and 
plasma cell maturation.  However, our investigation of mucosal priming shows that 
the predictive value of the clonal precursor assay is remarkably good. We determined 
the isotype profile of an intestinal response by two methods. First, the antigen-specific 
plasma cells in gut lamina propria that appear after toxin challenge in primed mice 
were scored with fluorescent anti-isotype stains. Second, similarly primed mice were 
scored by the elonal precursor assay for memory B cells and their isotype potential. 
Both techniques demonstrate a  preponderance of IgA expression, in lamina propria 
plasma  cells and  in  antigen-sensitive precursors residing  in  the  PP,  subsequent  to 
mucosal  priming.  Furthermore,  the  increased  expression  of IgG  after  parenteral 
priming is also evidenced by both techniques. 
This correspondence between B cell potential assessed in vitro and the actual  in 
vivo expression of different isotypes of plasma  cells permits  definition of a  special 
feature of priming for a  mucosal immune response. The most effective priming for 
secretory  immunity  should  result  in  a  high  frequency  of B  cells  committed  to 
generating clones expressing IgA exclusively. The recirculation of such cells and their 
lodging in mucosal follicles at surfaces exposed to secondary pathogenic insult would 
insure  the  most  rapid  and  efficient  source  of secretory  IgA  antibodies.  Clearly, 
mucosally applied  antigen  is  more effective than  parenteral  antigen  at  generating 
IgA-committed cells, and our results indicate that these cells are disseminated beyond 
the PP, where they initially encountered antigen, to MLN and spleen as well as to 
distant mucosal follicles. We believe that these IgA-committed cells which are found 
in the MLN and spleen after mucosal priming originated in the PP and migrated to 
distant sites after antigenic stimulation. The alternative, that they originated in the 
MLN or spleen and proliferated there in response to antigen leaked from the intestine 
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toxin in this dose range has never been shown to prime successfully for secretory IgA 
responses either in mice (7,  14) or in rats (24). 
Thus the route of priming is more influential than the ultimate tissue residence in 
determining the isotype profile of secondary B cells.  Mucosal priming establishes a 
differential in the concentration of IgA-committed B cells, so that PP contain more 
than spleen.  IgA-committed cells are also generated by parenteral priming, but  in 
much lower frequencies. We believe these observations indicate focal priming after 
mucosal stimulation and that cells committed to IgA increase in PP mainly through 
clonal expansion at  that  site, rather than  by accumulation  of IgA-committed cells 
which may be generated elsewhere. 
If local priming promotes the generation of IgA-committed cells in the PP, then the 
patch must provide a  unique environment which allows this specialized differentia- 
tion. We have previously proposed that VH-gene translocations within a  B cell line 
follow  a  division-dependent  vectorial  process  with  a  VH-C~  juxtaposition  as  the 
terminal consequence (19,  20).  Continual antigen-driven division in the absence of 
clonal attenuation through maturation to plasma cells should therefore increase the 
probability of arriving at a VH-C, recombination and concomitant IgA commitment. 
One  prediction  this  model  makes  is  that  secondary cells  generated  by parenteral 
priming, which normally yield clones expressing IgG +  IgA, could become committed 
to exclusive IgA expression as a result of further divisions in the PP. Ultimately, the 
special features of the patch milieu that abrogate plasma cell maturation must also be 
defined. These might include unique subsets of antigen-presenting cells and/or T cells 
(25-27). 
Although B cells committed to IgA expression may be generated in the PP, effective 
mucosal  immunity  requires  the  dissemination  of their  plasmablast  progeny.  The 
influence of antigen on the distribution of large lymphocytes in the mucosal system 
has been investigated by many workers.  Selective lodging of such cells is relatively 
independent of bacterial  or other enteric antigens  as suggested  from studies  using 
embryonic and neonatal gut explants  (28,  29).  However, an altered distribution of 
antigen-specific plasma cells has been demonstrated in response to localized antigen 
(9, 18). Both hormonal and tissue-specific influences have also been cited as influencing 
lymphoblast migration in cases where antigen gradients were unlikely to serve as a 
determining influence for lodging (30-33). We find that the antigen-specific memory 
B cells, which are the precursors for these plasmablasts and plasma cells, appear to 
distribute throughout the lymphoid system in an antigen-independent fashion. Fur- 
thermore, this dissemination yields a  persistent memory population at sites distant 
from the antigenic challenge, resulting in cross-priming among mucosal follicles. 
Summary 
Administration of cholera toxin/toxoid by either intraduodenal or parenteral routes 
increases  the  frequency of antigen-sensitive B  cells in  Peyer's patches  (PP)  and  in 
distant lymphoid tissues >  50-fold. The special feature ofmucosal priming with toxin 
is its unique effectiveness at generating secondary B cells, whose progeny express IgA 
exclusively, and  such  cells  appear  in  highest  frequency in  PP  and  in  appreciable 
numbers in spleen. Thus, this deliberate intraduodenal immunization seems to mimic 
the natural priming process induced by enteric bacterial colonization, which we have 
postulated  to  account  for the  high  frequencies of IgA-committed cells specific for JULIET A.  FUHRMAN AND JOHN J.  CEBRA  543 
bacterial  determinants  in  the  PP of conventionally reared  mice.  Furthermore,  as a 
result  of intraduodenal  immunization,  antigen-specific  memory B  cells  are  dissemi- 
nated to sites distant from that of antigen application, including the lymphoid follicles 
associated with the respiratory mucosa. Direct antigenic stimulation of cells in the PP 
therefore results in effective cross-priming among mucosal and systemic sites through 
division, differentiation,  and dissemination  of antigen-sensitive secondary B cells. 
Received  for publication 1 October 1980. 
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